BioNexus Gene Lab Corp. (BGLC) vs Mint Incorporation Limited (MIMI)
Over the past year, BGLC outperformed MIMI — -75.64% vs -98.99% annualized total return (price plus dividends).
A side-by-side comparison of BioNexus Gene Lab Corp. and Mint Incorporation Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
Total return — BGLC vs MIMI
growth of $100 · dividends reinvested · last 2yMetrics side by side
Did BGLC beat MIMI?
Over the past year, BGLC outperformed MIMI — -75.64% vs -98.99% annualized total return (price plus dividends).
Total return (annualized)
| Metric | BGLC | MIMI |
|---|---|---|
| Total return (1Y) | -75.64% | -98.99% |
| Total return CAGR (3Y) | -43.76% | N/A |
| Total return CAGR (5Y) | -61.00% | N/A |
MIMI is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Frequently asked
- Has BGLC beaten MIMI?
- Over the past year, BGLC outperformed MIMI — -75.64% vs -98.99% annualized total return (price plus dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.